New Year Bumper Sale @ Rs. 1 X
Macpod CV 200 Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Macpod CV 200 Tablet have also been mentioned below.
The correct dosage of Macpod CV 200 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Macpod CV 200 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Macpod CV 200 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Macpod CV 200 Tablet's effect during pregnancy is Mild and Moderate while nursing. Warnings related to Macpod CV 200 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Macpod CV 200 Tablet is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. Other contraindications of Macpod CV 200 Tablet have been discussed in the sections ahead.
Drug reaction of Macpod CV 200 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Macpod CV 200 Tablet is safe while driving, and is is addictive in nature.
Macpod CV 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Macpod CV 200 Tablet safe for pregnant women?
Pregnant women may get mild side effects from Macpod CV.
Is the use of Macpod CV 200 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Macpod CV. Immediately discontinue Macpod CV if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Macpod CV 200 Tablet on the Kidneys?
Kidney can be affected by Macpod CV. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Macpod CV 200 Tablet on the Liver?
Macpod CV may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Macpod CV 200 Tablet on the Heart?
Macpod CV may have mild side effects on the heart. Most people will never see any effect on the heart.
Macpod CV 200 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Macpod CV 200 Tablet unless your doctor advises you to do so -
Is this Macpod CV 200 Tablet habit forming or addictive?
No, there is no any evidence that Macpod CV 200 Tablet is addictive.
Interaction between Food and Macpod CV 200 Tablet
You can take Macpod CV 200 Tablet with food.
Interaction between Alcohol and Macpod CV 200 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Macpod CV 200 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311